Methylene blue alleviates nuclear and mitochondrial abnormalities in progeria.
about
Hallmarks of progeroid syndromes: lessons from mice and reprogrammed cellsAnti-Aging Potentials of Methylene Blue for Human Skin Longevity.Loss of H3K9me3 Correlates with ATM Activation and Histone H2AX Phosphorylation Deficiencies in Hutchinson-Gilford Progeria SyndromeComparing lamin proteins post-translational relative stability using a 2A peptide-based system reveals elevated resistance of progerin to cellular degradation.Oxidative status predicts quality in human mesenchymal stem cells.Metformin alleviates ageing cellular phenotypes in Hutchinson-Gilford progeria syndrome dermal fibroblasts.The Potential of iPSCs for the Treatment of Premature Aging Disorders.Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial.Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome.Protein sequestration at the nuclear periphery as a potential regulatory mechanism in premature aging.Shared molecular and cellular mechanisms of premature ageing and ageing-associated diseases.Lamin A and microtubules collaborate to maintain nuclear morphology.Methylene Blue Assay for Estimation of Regenerative Re-Epithelialization In Vivo.An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome.Evidence that S6K1, but not 4E-BP1, mediates skeletal muscle pathology associated with loss of A-type lamins.
P2860
Q26740026-DBD2410A-DE2C-4695-8ED8-D2B4B7EBEA1BQ33740320-EC9737FD-2B0A-4EA2-AA51-7192144AAC8EQ36210071-3FA57FEA-DC82-4281-9B74-4664AE07429BQ37558746-7D0CC895-E9FB-4D99-87E9-BF14F00FB162Q37566969-C5680723-7237-4EDF-9A7E-EB89F215998FQ46418627-057794F1-F168-409E-99D8-12ECF0683EFCQ47105441-C94CBC40-B98C-4ED0-9A5B-4B925EE4CEABQ47147322-624D7656-2B2A-49DD-A26F-5A3CDA46D749Q47414799-2BDE4C8A-8D33-4A67-A7B5-9E2E25CBF7AAQ47626666-3CBA9024-9DD2-4FDE-B244-D99B60C7A43DQ47974120-152EBCBB-7080-4D15-B451-C485A13EC7DBQ48357964-01AE38C0-40A9-439F-84AC-51DF3183C7A1Q50185384-02FA1A1C-6C10-4FB1-853B-1E28D847F17DQ55004770-CEB0B007-B45A-45AF-8FB5-6DA92BA69CEBQ55410665-75306A3F-6501-4AE0-875A-355CE771BE62
P2860
Methylene blue alleviates nuclear and mitochondrial abnormalities in progeria.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Methylene blue alleviates nuclear and mitochondrial abnormalities in progeria.
@en
type
label
Methylene blue alleviates nuclear and mitochondrial abnormalities in progeria.
@en
prefLabel
Methylene blue alleviates nuclear and mitochondrial abnormalities in progeria.
@en
P2093
P2860
P356
P1433
P1476
Methylene blue alleviates nuclear and mitochondrial abnormalities in progeria.
@en
P2093
Christina LaDana
Haoyue Zhang
Hiromi Sesaki
Ji Young Choi
Zeshan Tariq
Zheng-Mei Xiong
P2860
P304
P356
10.1111/ACEL.12434
P577
2015-12-14T00:00:00Z